Status:

TERMINATED

Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19

Lead Sponsor:

Chronic Obstructive Pulmonary Disease Trial Network, Denmark

Conditions:

Virus Diseases

Infection Viral

Eligibility:

All Genders

Phase:

PHASE2

Brief Summary

This study explores whether patients acutely hospitalized may have shorter hospitalization and fewer admittances at Intensive Care Units by treatment with azithromycin and hydroxychloroquine.

Detailed Description

In the ongoing coronavirus pandemic, COVID-19, that arose in Wuhan China, there is still sparse data in the course, risk of various complications, and in particular how patients who are hospitalized a...

Eligibility Criteria

Inclusion

  • Patient admitted to a Danish emergency department, lung medical department or medical department
  • Age \>18 years
  • Hospitalized \<48 hours
  • Positive COVID-19 test/diagnosis during the hospitalization
  • Signs informed consent

Exclusion

  • If the patient uses \> 5 LO2/min at time of recruitment
  • Known intolerance/allergy to azithromycin or hydroxychloroquine or hypersensitivity to quinine or 4-aminoquinolinderivates
  • Pregnancy
  • Breastfeeding
  • Neurogenic hearing loss
  • Psoriasis
  • Retinopathy
  • Maculopathy
  • Changes in vision field
  • Severe liver disease other than amoebiases
  • Severe gastrointestinal, neurological or haematological disorders
  • eGFR \< 45 ml/min/1.73m2
  • Clinically significant cardiac conduction disorders/arrhythmias or prolonged QTc interval
  • Myasthenia Gravis
  • Uses Digoxin
  • Glucose-6-phosphate dehydrogenase deficiency
  • Porphyria
  • Hypoglycemia at any time since hospitalization
  • Severe mental illness which significantly impedes cooperation
  • Severe linguistic problems that significantly impedes cooperation
  • Treatment with sickle alkaloids

Key Trial Info

Start Date :

April 6 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 2 2021

Estimated Enrollment :

117 Patients enrolled

Trial Details

Trial ID

NCT04322396

Start Date

April 6 2020

End Date

February 2 2021

Last Update

June 29 2021

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

Aalborg Sygehus

Aalborg, Denmark

2

Bispebjerg Hospital

Copenhagen, Denmark

3

Herlev-Gentofte Hospital

Copenhagen, Denmark

4

Hvidovre Hospital

Copenhagen, Denmark